CDZ has advised NanoGroup S.A., an advanced biotech company, on setting up a holding designed to generate added value by tapping into the group’s potential.

During the first stage of the project CDZ developed the group’s concept and drafted the documentation necessary to create the holding’s structure, while during the second stage CDZ is responsible for preparing the legal component of a prospectus that was filed with the Polish Financial Supervision Authority on May 23 and is another step towards the company’s listing at the Warsaw Stock Exchange.

The team is headed by Maciej Kotlicki and Piotr Rychta, assisted by Małgorzata Sas-Madej, who specializes in M&A deals and capital market law. Other team members included Aleksandra Hulewicz, Daniel Kozłowski, Monika Ciechomska and Marcin Lizurek.